drugset
Drugs / HPV (Types 16, 18) Vaccine, Adsorbed
last change Feb 2020 re-read 3 minutes ago

HPV (Types 16, 18) Vaccine, Adsorbed

also known as GSK580299 · Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed

Vaccine

Developed for
cervical intraepithelial neoplasia
Investigated by
GlaxoSmithKline

Trials 1

today NCT03629886 · Ph 4
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03629886 Aug 2018 → Feb 2020 cervical intraepithelial neoplasia GlaxoSmithKline Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HPV (Types 16, 18) Vaccine, Adsorbed ClinicalTrials.gov intervention name — accepted as the source's own label NCT03629886 ↗
Known as GSK580299 “Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study” NCT03629886 ↗
Known as Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed “Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study” NCT03629886 ↗
Modality Vaccine “Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed” NCT03629886 ↗
Route Intramuscular “administered intramuscularly in the deltoid region of the upper arm” NCT03629886 ↗